PT98272A - Processo para a preparacao de uma composicao farmaceutica para suspensao rapida em agua - Google Patents

Processo para a preparacao de uma composicao farmaceutica para suspensao rapida em agua

Info

Publication number
PT98272A
PT98272A PT98272A PT9827291A PT98272A PT 98272 A PT98272 A PT 98272A PT 98272 A PT98272 A PT 98272A PT 9827291 A PT9827291 A PT 9827291A PT 98272 A PT98272 A PT 98272A
Authority
PT
Portugal
Prior art keywords
water
pct
drug
pharmaceutical composition
suspension
Prior art date
Application number
PT98272A
Other languages
English (en)
Other versions
PT98272B (pt
Inventor
Luigi Giovanni Mappeli
Marco Zema
Marco Giuseppe Raffael Marconi
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Publication of PT98272A publication Critical patent/PT98272A/pt
Publication of PT98272B publication Critical patent/PT98272B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B2275/00—Other engines, components or details, not provided for in other groups of this subclass
    • F02B2275/14—Direct injection into combustion chamber

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
PT98272A 1990-07-11 1991-07-10 Processo para a preparacao de uma composicao farmaceutica para suspensao rapida em agua PT98272B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02090890A IT1246350B (it) 1990-07-11 1990-07-11 Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili

Publications (2)

Publication Number Publication Date
PT98272A true PT98272A (pt) 1992-05-29
PT98272B PT98272B (pt) 1999-01-29

Family

ID=11173904

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98272A PT98272B (pt) 1990-07-11 1991-07-10 Processo para a preparacao de uma composicao farmaceutica para suspensao rapida em agua

Country Status (16)

Country Link
US (1) US5306506A (pt)
EP (1) EP0491910B1 (pt)
JP (1) JP2552785B2 (pt)
KR (1) KR100209175B1 (pt)
AT (1) ATE113832T1 (pt)
AU (1) AU640253B2 (pt)
CA (1) CA2046679C (pt)
DE (1) DE69105106T2 (pt)
DK (1) DK0491910T3 (pt)
ES (1) ES2064112T3 (pt)
IE (1) IE66048B1 (pt)
IT (1) IT1246350B (pt)
NZ (1) NZ238901A (pt)
PT (1) PT98272B (pt)
WO (1) WO1992000731A1 (pt)
ZA (1) ZA915284B (pt)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0662320T3 (da) * 1991-08-30 2001-09-24 Showa Pharm Chem Ind Tør gelsammensætning
US6673335B1 (en) * 1992-07-08 2004-01-06 Nektar Therapeutics Compositions and methods for the pulmonary delivery of aerosolized medicaments
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
ATE220327T1 (de) * 1992-09-29 2002-07-15 Inhale Therapeutic Syst Pulmonale abgabe von aktiven fragmenten des parathormons
EP0624364B1 (de) * 1993-04-15 1996-07-24 Gerhard Dr. Gergely Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
EP0867426B1 (de) * 1993-09-07 2002-06-26 Gerhard Dr. Gergely Modifizierte Kristalle einer festen, essbaren, organischen Säure
FR2712809B1 (fr) * 1993-11-26 1996-04-12 Union Pharma Scient Appl Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
ES2218543T3 (es) * 1994-03-07 2004-11-16 Nektar Therapeutics Procedimiento y preparacion para la administracion de insulina por via pulmonar.
EP0678241B1 (en) * 1994-04-11 2001-11-07 Dsm N.V. Stable natamycin suspensions
NZ285664A (en) * 1994-05-18 1998-07-28 Inhale Therapeutic Syst Dry powder interferon composition adapted for pulmonary delivery
WO1995033490A1 (en) * 1994-06-02 1995-12-14 Enzon, Inc. Method of solubilizing substantially water insoluble materials
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
CZ88697A3 (en) 1994-09-22 1997-09-17 Quadrant Holdings Cambridge Composition used for re-hydration and nourishment in the course of athletic outputs and processes for preparing thereof
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
BE1009380A3 (nl) * 1995-03-14 1997-03-04 Universiteit Gent Lab Voor Far Stabiliserend samenstelling voor suspensie.
US6964771B1 (en) * 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5560928A (en) * 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US5712310A (en) * 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
FR2753097A1 (fr) * 1996-09-11 1998-03-13 Barrau Francois Gel aqueux ou hydroalcoolique extemporane a viscosite controlee
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
US6468782B1 (en) * 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US20030035778A1 (en) * 1997-07-14 2003-02-20 Robert Platz Methods and compositions for the dry powder formulation of interferon
IN186245B (pt) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
NZ333474A (en) 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
IL136899A0 (en) * 2000-06-20 2001-06-14 Caretec Ltd Microcapsules containing arginine and the different uses thereof
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
EP1339395A2 (en) 2000-11-28 2003-09-03 Fmc Corporation Edible pga (propylene glycol alginate) coating composition
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6607784B2 (en) 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
TWI327474B (en) * 2001-04-06 2010-07-21 Neochemir Inc Kit for preparation of carbon dioxide agent for external use.
AU2002337692B2 (en) 2001-09-26 2007-09-13 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
ITMI20022358A1 (it) * 2002-11-07 2004-05-08 Bsd Bioscience Dev Snc Composizioni farmaceutiche effervescenti per la realizzazione di sospensioni non convenzionali.
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20050095320A1 (en) * 2003-10-29 2005-05-05 Richard Botteri [An Isotonic Sports Drink for Female Athletes Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Nutrition During Execise and Competition]
US20050100636A1 (en) * 2003-11-10 2005-05-12 Megan Botteri [A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity]
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
AU2008218595B2 (en) * 2007-02-20 2012-05-24 Allergan Therapeutics LLC Stable digestive enzyme compositions
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
US7782646B2 (en) * 2008-06-30 2010-08-24 International Business Machines Corporation High density content addressable memory using phase change devices
UA111726C2 (uk) 2010-10-01 2016-06-10 Апталіс Фарма Лімітед Препарат панкреліпази низької сили з кишковорозчинним покриттям
MX351014B (es) 2011-08-08 2017-09-28 Aptalis Pharma Ltd Metodo para la prueba de disolucion de composiciones solidas que contienen enzimas digestivas.
KR101383908B1 (ko) 2012-10-29 2014-04-10 씨앤텍 주식회사 이산화탄소를 피부에 공급하는 팩과 그 제조방법
JP5993336B2 (ja) * 2013-04-26 2016-09-14 株式会社メディオン・リサーチ・ラボラトリーズ 二酸化炭素経皮・経粘膜吸収用組成物
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
CN106163544A (zh) 2013-08-09 2016-11-23 阿勒根制药国际有限公司 适于经肠施用的消化酶组合物
CN108368527B (zh) 2015-11-26 2023-07-18 诺维信公司 研磨方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2125577A (en) * 1936-09-10 1938-08-02 Matsumae Akiyoshi Auxiliary medical agent and method of preparing the same
US3928252A (en) * 1971-12-10 1975-12-23 Adolph S Ltd Thickened food
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions

Also Published As

Publication number Publication date
KR100209175B1 (ko) 1999-07-15
ES2064112T3 (es) 1995-01-16
ZA915284B (en) 1993-03-31
EP0491910B1 (en) 1994-11-09
JP2552785B2 (ja) 1996-11-13
DE69105106D1 (de) 1994-12-15
KR920702215A (ko) 1992-09-03
DK0491910T3 (da) 1995-01-09
DE69105106T2 (de) 1995-04-27
IT1246350B (it) 1994-11-17
US5306506A (en) 1994-04-26
CA2046679C (en) 2001-11-20
IE912382A1 (en) 1992-01-15
IT9020908A1 (it) 1992-01-11
CA2046679A1 (en) 1992-01-12
EP0491910A1 (en) 1992-07-01
WO1992000731A1 (en) 1992-01-23
JPH05501421A (ja) 1993-03-18
ATE113832T1 (de) 1994-11-15
IT9020908A0 (it) 1990-07-11
IE66048B1 (en) 1995-12-13
PT98272B (pt) 1999-01-29
NZ238901A (en) 1992-08-26
AU640253B2 (en) 1993-08-19
AU8183391A (en) 1992-02-04

Similar Documents

Publication Publication Date Title
ZA915284B (en) Pharmaceutical composition for rapid suspension in water
IT1248702B (it) Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
IL89276A0 (en) Human relaxin formulation
ATE157867T1 (de) Geschmacksmaskierende zusammensetzungen von ranitidin
GR3022536T3 (en) A gel-forming liquid carrier composition
CS590188A2 (en) Method of erythropoietin's stabilized preparation production
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
DK74187D0 (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
IL74707A (en) Anti-viral compositions comprising pyridazinamines,certain such novel compounds and their preparation
ES2052682T3 (es) Una composicion farmaceutica potenciadora de la penetracion para aplicacion topica.
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
FI884955A0 (fi) Konserverade haor- och hudrengoeringsmedel och anvaendning av en konserveringsmedelkombination.
EP0173664A3 (en) Biologically active benzimidazole compounds and process for their preparation
GB9424766D0 (en) Pharmaceutical composition
GR3036966T3 (en) Stabilized pseudo-emulsions and their preparation process
EE03087B1 (et) Adenosiini derivaadid, nende valmistamise meetodid ja neid sisaldavad ravimvormid
DE69401502D1 (de) Arzneizubereitung zum Herstellen eines stabilisierten Pulvers das eine Kombination aus Acetylsalicylsäure und Metoclopramid als Wirkstoff enthält
ATE246515T1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
AU554548B2 (en) Potassium-neutral salureticum with antihypertensive effect
DK527186D0 (da) Bronchodilaterende farmaceutisk praeparat
TW261605B (pt)
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
MX9301627A (es) Agente para utilizarse como un antiirritante y composicion que lo contiene.
JPH0334919A (ja) 浴用剤

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920120

FG3A Patent granted, date of granting

Effective date: 19981002